scholarly article | Q13442814 |
P2093 | author name string | Mohammad Kazemi | |
Batool Hashemibeni | |||
Nazem Ghasemi | |||
Mitra Soleimani | |||
Anooshe Zargar | |||
Mohsen Setayeshmehr | |||
Mona Gorji | |||
P2860 | cites work | Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications | Q26829998 |
Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk | Q28191426 | ||
p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells | Q33178681 | ||
The restoration of full-thickness cartilage defects with BMSCs and TGF-beta 1 loaded PLGA/fibrin gel constructs. | Q33686537 | ||
Regulation of human adipose-derived stromal cell osteogenic differentiation by insulin-like growth factor-1 and platelet-derived growth factor-alpha. | Q34470598 | ||
Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect | Q35025058 | ||
The dawning era of polymer therapeutics | Q35128900 | ||
Nanoparticles and their potential for application in bone | Q36177552 | ||
Strategies to improve plasma half life time of peptide and protein drugs | Q36452632 | ||
Electrospinning of polymeric nanofibers for tissue engineering applications: a review | Q36505561 | ||
Fibrin and poly(lactic-co-glycolic acid) hybrid scaffold promotes early chondrogenesis of articular chondrocytes: an in vitro study | Q36688451 | ||
Advances and challenges of nanotechnology-based drug delivery systems. | Q36985900 | ||
Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications. | Q37947952 | ||
Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line | Q39306623 | ||
Legal aspects of the risks raised by nanotechnologies in the field of medicine | Q39716429 | ||
In vivo and in vitro anti-inflammatory effects of a novel derivative of icariin | Q39722925 | ||
Production of collagens, collagenase and collagenase inhibitor during the dedifferentiation of articular chondrocytes by serial subcultures | Q41740698 | ||
VEGF gene delivery to myocardium: deleterious effects of unregulated expression | Q41757138 | ||
Icariin protects murine chondrocytes from lipopolysaccharide-induced inflammatory responses and extracellular matrix degradation | Q43179900 | ||
Enhancement of chondrogenesis of human adipose derived stem cells in a hyaluronan-enriched microenvironment | Q43263958 | ||
Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression | Q43277758 | ||
Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering | Q43577924 | ||
Novel nanocomposite coating for dental implant applications in vitro and in vivo evaluation | Q43656317 | ||
Chondrocytes seeded onto poly (L/DL-lactide) 80%/20% porous scaffolds: a biochemical evaluation | Q44549253 | ||
Electrospun nano- to microfiber fabrics made of biodegradable copolyesters: structural characteristics, mechanical properties and cell adhesion potential. | Q45207161 | ||
Fibrin nanoconstructs: a novel processing method and their use as controlled delivery agents. | Q45942159 | ||
An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis. | Q46012525 | ||
Effect of pore size on ECM secretion and cell growth in gelatin scaffold for articular cartilage tissue engineering | Q47210246 | ||
Porous poly(lactic-co-glycolic acid) microsphere as cell culture substrate and cell transplantation vehicle for adipose tissue engineering | Q47732061 | ||
The use of fibrin and poly(lactic-co-glycolic acid) hybrid scaffold for articular cartilage tissue engineering: an in vivo analysis. | Q47900464 | ||
Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. | Q50486810 | ||
Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. | Q50734388 | ||
Chondrogenic differentiation of amniotic fluid-derived stem cells. | Q50946606 | ||
Fibrin nanoparticles as Possible vehicles for drug delivery. | Q51019719 | ||
Cartilage regeneration using mesenchymal stem cells and a three-dimensional poly-lactic-glycolic acid (PLGA) scaffold. | Q51546415 | ||
Controllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I: physical, chemical, and theoretical aspects. | Q51705305 | ||
Nano‐fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment | Q51810331 | ||
Local BMP-7 release from a PLGA scaffolding-matrix for the repair of osteochondral defects in rabbits. | Q53364398 | ||
Cartilage Tissue Engineering Via Icariin and Adipose-derived Stem Cells in Fibrin Scaffold. | Q54095350 | ||
Icariin: a potential promoting compound for cartilage tissue engineering. | Q54295423 | ||
Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation | Q77301189 | ||
Icariin promotes extracellular matrix synthesis and gene expression of chondrocytes in vitro | Q83394401 | ||
In situ chondrogenic differentiation of human adipose tissue-derived stem cells in a TGF-beta1 loaded fibrin-poly(lactide-caprolactone) nanoparticulate complex | Q84058694 | ||
P921 | main subject | nanoparticle | Q61231 |
cartilage development | Q5104524 | ||
P304 | page(s) | 6 | |
P577 | publication date | 2020-02-25 | |
P1433 | published in | Advanced biomedical research | Q27724488 |
P1476 | title | The Effects of Fibrin-icariin Nanoparticle Loaded in Poly (lactic-co-glycolic) Acid Scaffold as a Localized Delivery System on Chondrogenesis of Human Adipose-derived Stem Cells | |
P478 | volume | 9 |
Search more.